Standing Issue Threatens 15 Zometa Suits In NJ
A New Jersey judge has dismissed 15 lawsuits over Novartis Pharmaceuticals Corp.'s bone-strengthening drug Zometa, based on a failure to file certain documents intended to show that the cases belonged in...To view the full article, register now.
Already a subscriber? Click here to view full article